angiotensin may be involved, at some stages at least, in the mechanisms of renal hypertension, but more evidence is needed to define clearly how it is concerned. Elsewhere 1 we have described the sequence of hemodynamic events that occurs during development of experimental renal hypertension due to renal artery constriction in trained, resting dogs. This was made possible by using an implanted flow transducer to measure cardiac output, together with a catheter to measure blood pressure.
We have attempted to determine whether these hemodynamic changes are reproduced in normal dogs by continuous administration of angiotensin n. Despite practical difficulties, three successful shorter experiments (2, 5, and 6 days) and five longer ones (8 to 29 days) provided sufficient data for this comparison.
Methods
Dogs were prepared for hemodynamic study, as in the preceding report on experimental renal hypertension, by implanting a flow probe on the ascending aorta and an arterial catheter in the aortic arch. The apparatus and the recorded cardiovascular factors were the same as before. 1 In addition, a catheter for infusion was placed in the superior vena cava through an external jugular vein. This catheter terminated externally in a skin button located at the back of the neck. The catheter was closed, when not in use, by a Luerlok taper fitting and was filled with 50 mg/ml heparin to prevent clotting. Training and control studies were done as before.
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through a fine plastic tube in a speedometer cable housing suspended from a fluid-conducting swivel joint on the ceiling. Angiotensin was dissolved in 5% glucose in water, which was cooled to below 10°C to inhibit bacterial growth. Flow rate was regulated by a small peristalic pumpt delivering 0.25 ml/min to the swivel joint and venous catheter. Dosage is given in nanograms per kilogram body weight per minute (ngAg/min). The dogs lived in the laboratory. In five later experiments the dogs wore a shoulder harness carrying a syringe pumpt driven by gas produced by electrolysis. Ten ml of angiotensin solution in saline were administered during 24 hours; concentration was 60 to 120 ^ig/ml at the start of the procedure, and was increased from time to time to maintain the pressor effect. The starting rate for all infusions ranged from 15 ng/kg/min to 35 ng/kg/min, and was adjusted depending upon the individual pressor sensitivity of the dogs. This second group of animals lived in kennel cages except for periods of training and recording in the laboratory.
The general health of the dogs was assessed by their changes of weight and behavior. One of the animals gained weight, two did not change, and four lost 1 to 4 kg during a period of four to eight weeks after installation of flow probes and catheters. In addition, periodic determinations showed that hemoglobin remained within normal limits. Hematocrits increased slightly during longer infusions.
Results
Eight trained dogs were infused continuously with angotensin for 2 to 29 days. In three experiments lasting 2, 5, and 6 days, the infusion rate was constant while in five longer ones, that lasted 8, 12, 21, 28, and 29 days, it was necessary to increase it at intervals of 1 to 9 days in order to maintain an elevation of mean arterial pressure ranging from 16 to 69 mm Hg above control values. At least one recording, varying in duration from 15 minutes to 6 hours, was made every day. The total number of recordings was 179, not including 40 control tracings. Usually the infusion was turned off for 5 to 20 minutes once a day for refilling the syringe pump. This was considered a test period, and the effects of stopping the infusion were recorded.
Four responses to angiotensin infused for long periods were considered. The first was the immediate response at the start of the infusion. The second was the circulatory adaptation to continuous moderate elevation of arterial pressure, and the third the reactions to discontinuing the infusion. The fourth was a transient response simulating the hemodynamic pattern of the "malignant" stage of experimental renal hypertension. 2 In the two-day infusion the initial response to 35 ng/kg/min of angiotensin appears in figure 1 . Accompanying the rise of arterial pressure by 50/35 mm Hg, cardiac output and heart rate decreased, and peripheral resistance rose. Stroke volume did not change significantly. Pulse pressure was widened and the dicrotic notch appeared high on the pressure curve. These changes were maintained during the 46 hours of infusion. Almost identical responses to infusion rates of 15 to 35 ng/kg/min occurred in most of the seven other dogs (table 1).
In the five-and six-day infusions, in which the dose of angiotensin was constant, similar initial circulatory changes were seen in one experiment while in the other there was no immediate alteration of cardiac output and heart rate rose slightly. A few hours later cardiac output and heart rate in this latter dog fell below control values. In both infusions, on the third or fourth day all values began to return toward control levels and were near them by the fifth and sixth days in spite of continued infusion. Similar results
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FIGURE 1
Left section shows control recording of flow (channel numbered 1), with regular left ventricular ejection curves; 2) arterial blood pressure 90/60 mm Hg; 3) cardiac output 3 to 3.2 liters/nun and stroke volume 35 ml; 4) mean arterial pressure 75 mm Hg; 5) heart rate 88/min, and 6) peripheral resistance; quotient of mean pressure/cardiac output at 4 sec-intervals. Right section shows response 20 minutes after start of infusion of angiotensin at 35 ng/kg/min. Ventricular ejections were slower and uneven. Pulse pressure was widened, cardiac output reduced, and mean pressure elevated by 35 mm Hg. Heart rate was reduced, peripheral resistance increased. were obtained during the first week of two of the longer infusions which were started at 30 ng/kg/min and in which dosages were not increased until the hemodynamic status had reverted to normal.
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In the three other longer infusions, values were prevented from returning to normal by increasing infusion rates when pressure started to decrease. The complete course of a 28day infusion is shown in table 2. This was started at approximately half the dosage rate (15 ngAg/min) of the others. Although cardiac output decreased at the start, heart rate increased, and strikingly so on the second day, with a corresponding decrease of stroke volume. It was not until the dosage of angiotensin had been increased to 30 ng/kg/min for 24 hours that heart rate decreased to below control values. From the tenth day onward cardiac output tended to return toward control level and was sometimes above it On the last two days of the infusion, even with greatly increased dosage of angiotensin, cardiac output was normal or above. On the last day of the infusion increase in dosage of angiotensin had little effect on either arterial pressure or cardiac output. For the second half of the infusion, cardiac output and heart rate were near normal levels, while peripheral resistance remained elevated. These changes also appeared during the other longer infusions, occurring earlier on the third, fourth, and sixth days after initiation of pressure rise. This group of changes is also shown in figure 2. First appears a test period when the infusion was off and arterial pressure below control level. Restarting the infusion was accompanied by changes similar to those in the initial phase during which cardiac output and heart rate were reduced and peripheral resistance was elevated. The recording was continuous for six hours, at the end of which, while arterial pressure remained raised to the same level as at the start of the infusion, cardiac output had returned to the control value, and heart rate nearly so.
Elevation of mean arterial pressure above control values ranged during the infusion from 16 to 69 mm Hg. This elevation was not maintained at a stable level from day to CircmUiitm Riurcb, Vol. XVI, Ptiriurj 1965 day, nor were dosage rates adjusted to elicit a maximal rise in arterial pressure. Usually mean pressure was increased about 35 mm Hg, which was below the values we observed in experimental renal hypertension, where in the chronic state, increases ranged from about 50 to 100 mm Hg. 1 If enough angiotensin was infused to duplicate these levels, particularly during the first three to four days of an infusion, partial loss of response to angiotensin occurred within a few hours and pressure fell toward the control value.
However, a week to 10 days after the start of the experiments, temporary but larger responses to angiotensin were sometimes observed. These followed when the infusion rate was increased by 20 to 30 ngAg/min, dosage, before, the increase having ranged from 30 to 60 ngAg/min. One of these responses is shown in figure 3 . When the infusion rate was increased, arterial pressure rose to 200/130 mm Hg, and mean pressure to about 60 mm Hg above control value. Heart rate and peripheral resistance increased, but stroke volume decreased. These responses occurred in all the five longer infusions and persisted for 6 to 48 hours, after At t/ie extreme left the infusion, previously in progress for six days, was temporarily discontinued. Cardiac output and heart rate were high, arterial pressure and peripheral resistance low. At arrow the infusion was restarted, causing decrease of cardiac output, moderate rise of arterial pressure, decrease of heart rate and rise of resistance. The recording and infusion were continuous for six hours; the right hand section shows its conclusion. The rise in arterial pressure was maintained, but cardiac output returned to control levels, and heart rate nearly to control levels. Peripheral resistance was not as high as it was at the time the angiotensin infusion was restarted.
which arterial pressure returned to its usual and more moderate elevation above control level.
The phase in which cardiac output had returned to normal values, while arterial pressure and peripheral resistance were elevated, could be maintained if the dose of angiotensin was increased by 10 to 30 ng/kg/min every few days. Figure 4 shows that arterial pressure rose and fell during a period of several days. The rising side of the curve followed the increments in dosage, the falling side ensued in the next few days at constant infusion rate. During the first part of this experiment cardiac output decreased when angiotensin was infused, but in the last few days this change became small. The main effects were increased arterial pressure and peripheral resistance, accompanied by mod-erately reduced heart rate and increased stroke volume. The effect on the heart was then a large increase in work load, to which it was able to respond.
Extremely high pressure could be produced during the infusions by substantial additional increase of infusion rates (200 to 400 ngAg/ min), but a limit of pressure rise appeared in the range of 250/150 to 260/170 mm Hg, because further increase in dosage decreased arterial pressure. These high levels could be maintained for. only one or two hours, after which blood pressure fell toward control values. Figure 5 shows the sharply decreased cardiac output, with reduced irregular stroke volume, that appeared while arterial pressure and peripheral resistance were greatly elevated. On these occasions it was necessary to raise the rate of infusion carefully because, if the dosage was too high, the response to angiotensin diminished rapidly.
When the infusions were temporarily discontinued, arterial pressure, stroke volume, and peripheral resistance fell below control levels, while heart rate and cardiac output rose sharply ( fig. 6 ). Similar changes were noted at the end of most long-term infusions. During the following day or two, circulation returned to control values although the initial sensitivity to angiotensin, as measured by short infusions, did not return for a week or two as determined in two dogs.
The circulatory effects of angiotensin seem to depend on dosage and on individual sensitivity of the dogs. Table 1 shows that the largest initial response of arterial pressure (50/60 mm Hg) was caused by the smallest starting dose (15 ng/kg/min), while the largest initial infusion rate, 35 ng/kg/min, in one dog produced the smallest response (12/22 mm Hg) and in another dog a rise of 50/35 a s -. • mm Hg. In the five longer infusions it was possible to elicit for several hours to several days (e.g., fig. 3 ) an increase in mean arterial pressure of 50 to 60 mm Hg, comparable to that seen in experimental renal hypertension. These responses appeared when dosage ranged from 40 to 90 ng/kg/min.
Discussion
Comparison of the initial hemodynamic responses to angiotensin with those at the onset of experimental renal hypertension 1 reveals marked similarity. In both groups of experiments when arterial pressure was first elevated, cardiac output and heart rate decreased and peripheral resistance increased. Pulse pressure was widened and the contours were the same in both. Stroke volume decreased when mean pressure was raised 50 to 60 mm Hg above control levels by increasing still more the dosage of infused angiotensin, or when large amounts of it were used to -ONE SEC
FIGURE 3
After 10 days of infusion, at arrow, dosage rate was increased from 40 to 70 ng/kg/min. Systolic arterial pressure increased to a maximum of 200 mm Hg, and mean pressure to 150 mm Hg, nearly 60 mm Hg above control values. Cardiac output was not affected, but heart rate and peripheral resistance were increased. Stroke volume was decreased, and the left ventricular ejection curve more rounded than usual at its peak. Usual values from day to day during a 29-day infusion of angiotensin. The white bars represent control levels, and the black bars the results of infusion. The groups of five whtte bars at the left show the training period. The white bars next to the black ones show the control levels each day when infusion was stopped temporarily to permit refilling the syringe pump. With each increment of dosage arterial pressure increased for a few days, but then fell toward normal. Final dosage was 175 ng/kg/min; on the ninth day at this infusion rate arterial pressure returned toward control values. Cardiac output was decreased at the start of the infusion, but at the end cardiac output was not changed by angiotensin.
duplicate the hemodynamic pattern of experimental "malignant" renal hypertension. Occasional small strokes were seen at the onset of renal and infusion hypertension, but not frequently enough to affect the average value significantly. Both in dogs receiving angiotensin and in those with induced renal hypertension, cardiac output and heart rate returned to control levels after a few days, while peripheral resistance remained elevated. The only differ-ence noted was that when arterial pressure was elevated by angiotensin to the higher levels characteristic of experimental renal hypertension, stroke volume was reduced whereas it was not reduced by renal artery constriction.
To keep arterial pressure elevated, it was necessary to increase the infusion rate of angiotensin at intervals of from one to nine days by increments of 10 to 60 ng/kg/min, and in three to four weeks pronounced tolerance developed. In hypertension induced by renal artery constriction, arterial pressure remained high, while the hypertension produced by a constant infusion of angiotensin decreased gradually over several days.
A "malignant" or accelerated phase of hypertension is sometimes seen in experimental renal hypertension caused by severe constriction of a renal artery. 2 This is accompanied by vascular lesions resembling those occurring in malignant hypertension in man. We have found in such dogs a hemodynamic pattern of high peripheral resistance, reduced cardiac output, and a wide, triangular pressure curve in which the dicrotic notch is close to the peak systolic point. 1 For short periods, in dogs receiving angiotensin, this hemodynamic pattern could be reproduced by greatly increased doses of angiotensin, but only for several hours.
Restoration of cardiac output and heart rate to control values after one or two weeks of infusion seems due to adaptation of pressure regulatory mechanisms. 3 This could also explain the failure of elevated arterial pressure to slow the heart rate significantly or reduce cardiac output at the end of the 29day infusion (e.g., fig. 4 ). In addition, angiotensin may have had some inotropic effect. 4 Angiotensin has been infused into unanesthetized rabbits for prolonged periods. Arterial pressure was recorded or measured intermittently, but no other hemodynamic factors were recorded or measured. Dickinson and Lawrence 3 used a dosage rate of from 5 to 10 ng/kg/min, less than our smallest, High arterial pressure and peripheral resistance, with decreased cardiac output resulting from rapid infusion of angiotensin at rate of 275 ng/kg/min. The pulse pressure was oddly triangular and the dicrotic notch followed closely the peak of systole. The ventricular ejection curves were irregular. Effects of discontinuing the infusion for a few minutes on the twenty third day of a 28-day infusion. Between the arrows the infusion teas momentarily stopped. Fall of blood pressure to below control level was rapid, as was increase of cardiac output and heart rate, and decrease of stroke volume and peripheral resistance. At start of the infusion the ventricular ejection curves were uneven, but on the twenty third day they were regular. Arterial pressure was almost the same on both days. 
Summary
Arterial pressure, cardiac output, stroke volume, heart rate, and peripheral resistance have been recorded daily in eight trained, healthy dogs with implanted aortic flow probes and aortic catheters. After suitable control periods angiotensin n was infused for periods of from 2 to 29 days.
The effects observed were considered under four categories: 1) The immediate effects consisted of rise of arterial pressure, decrease of cardiac output and heart rate, rise of peripheral resistance and increased pulse pres- sure. Within five days all values tended to return to control levels unless the infusion rate of angiotensin was increased. 2) A chronic phase followed and, during this period, cardiac output was normal while arterial pressure and peripheral resistance were elevated. 3) After infusions were stopped pressure and peripheral resistance rapidly declined to below normal, while cardiac output and heart rate rose to above normal. 4) A transient "malignant" phase was elicited by very large increases in the rate of angiotensin infusion, during which cardiac output and stroke volume were diminished while arterial pressure and peripheral resistance were increased greatly.
The hemodynamic changes resulting from prolonged angiotensin infusion were similar in some respects to those found by us during the onset of hypertension due to renal artery constriction in dogs. They differed, however, in that doses of angiotensin, which were great enough to induce arterial pressure elevations similar to those of chronic experimental renal hypertension, reduced stroke volume, and these higher pressures could not be maintained for more than a few days. Hypertension did not persist after discontinuing angio-tensin even after 28 days of almost continuous infusion. There was a distinct tendency for the pressor response to diminish with passage of time; more angiotensin was required to maintain similar elevations of arterial pressure.
